Last reviewed · How we verify

NCT05213013

The Effect of Toy-Type Nebulizer on Fear and Anxiety in Children Receiving Inhaler Treatment

Status unknown NA Last updated 8 February 2023
What this trial tests

NA trial testing inhaler treatment with the toy-type nebulizer and training on on the use of a nebulizer/mask in Children, Only in 64 participants. Status unknown.

Timeline
30 January 2022
Primary endpoint
28 January 2023
30 January 2023

Quick facts

Lead sponsorAylin Kurt
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment64
Start date30 January 2022
Primary completion28 January 2023
Estimated completion30 January 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Aylin Kurt

Who can join

Adults 4 to 10, any sex, with Children, Only or Fear Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine the effect of toy-type nebulizers on fear and anxiety in children receiving inhaler therapy. The research hypotheses are as follows: H0: There is no significant difference between the intervention group and the the control group in the mean score of the "Child Fear Scale" and "Child Anxiety Scale-State" during and after the inhaler treatment with a toy-type nebulizer. H1: During and after the s inhaler treatment with the toy-type nebulizer, the mean score of the "Child Fear Scale" and "Child Anxiety Scale-State" is significantly higher in the intervention group compared to the control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Children, Only

Currently open trials in the same condition.

Other Aylin Kurt trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05213013.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing